Navigation Links
Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
Date:5/8/2012

This Phase Ib study was an open-label clinical trial of eTNS™ therapy in adults with non-psychotic unipolar MDD that had lasted more than 4 months and had not responded to at least one antidepressant, with a median of 4 medication failures.  Clinical improvements were consistently found across several different ways to measure symptom burden.  

The TNS technology, including eTNS™ for the treatment of depression, was invented and originally developed at UCLA.  NeuroSigma, Inc., a Los Angeles-based medical technology company established to in-license and develop early stage technologies with the potential to transform medical practice, is the exclusive worldwide licensee of UCLA's TNS intellectual property.  "We are extremely pleased to be working closely with Dr. Cook and his talented and dedicated team at UCLA," said Dr. Leon Ekchian, President and CEO of NeuroSigma.  "We look forward to helping make his vision of a safe, non-invasive, non-pharmacological therapy for depression available to patients worldwide."

NeuroSigma has completed development of its external TNS (eTNS™) system and is developing its implantable subcutaneous TNS (sTNS™) system.  Once approved by regulatory agencies, patients who respond well to eTNS™ can opt to switch to the implantable sTNS™ system.  Near term milestones include filing a CE Mark application in mid-2012 for approval to commence marketing the eTNS system for the treatment of epilepsy and depression in Europe, and in the second-half of 2012, NeuroSigma is planning to file an IDE with the FDA for a multi-center epilepsy Phase III pivotal trial in the United States. 

Background – TNS

NeuroSigma's eTNS™ system is a non-invasive therapy, which utilizes a self-adhesive conductive pad applied to the forehead to stimulate branches of the trigeminal nerve, which are located very close to the surface of the skin of th
'/>"/>

SOURCE NeuroSigma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PDI, Inc. to Hold First Quarter 2012 Financial Results Conference Call on Tuesday, May 15, 2012
2. Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results
3. AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results
4. Par Pharmaceutical Companies Reports First Quarter 2012 Results
5. InspireMD Announces First Quarter 2012 Financial Results
6. Stereotaxis Reports Improved First Quarter 2012 Financial Results
7. Henry Schein Reports Record First Quarter Results
8. Isis Reports Financial Results and Highlights for First Quarter 2012
9. Insmed Announces First Quarter 2012 Financial Results
10. Vanda Pharmaceuticals Reports First Quarter 2012 Results
11. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015  Anpac Bio-Medical Science Co., Ltd., Chief Executive ... the Anpac research team are introducing what the 2015 ... published as, "game changing" and "breakthrough" early cancer detection ... Oncology (ASCO) Annual Meeting in Chicago, Illinois ... An accomplished inventor with over 200 patent ...
(Date:5/29/2015)... DUBLIN , May 28, 2015 Research ... of the "North America Open System MRI Market ... report to their offering. The key players ... , Philips Healthcare, Siemens Healthcare and Toshiba Medical Systems ... tool which is replacing CT because of its higher ...
(Date:5/29/2015)... SPARTANBURG, South Carolina , May 29, ... and Molecular Health have announced a collaboration designed to ... support to the majority of cancer patients living in ... collaborate with Molecular Health to harness the power of ... from hundreds of thousands of patients to enable ,accrual ...
Breaking Medicine Technology:Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 2Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 3North America Open System MRI Market 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare and Toshiba Medical Dominating 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4
... BioCryst,Pharmaceuticals, Inc. (Nasdaq: BCRX ) today ... of the preliminary Phase II data and ... (i.m.) peramivir., (Logo: http://www.newscom.com/cgi-bin/prnh/20030414/BIOCRYSTLOGO ... II results in September 2007,the Company completed ...
... COGNISION Headset to Begin This Month ... at the University of ... University,of Kentucky Sanders-Brown Center on Aging are launching an Alzheimer,s,screening ... study will involve brainwave assessments,using a technology called event-related potentials ...
Cached Medicine Technology:BioCryst Updates Peramivir Clinical Development Plan 2BioCryst Updates Peramivir Clinical Development Plan 3BioCryst Updates Peramivir Clinical Development Plan 4BioCryst Updates Peramivir Clinical Development Plan 5BioCryst Updates Peramivir Clinical Development Plan 6Innovative Brain Scanning for Alzheimer's Screening Unveiled 2
(Date:5/29/2015)... May 29, 2015 The campaign focuses ... as a number of specific concerns within, including the ... and mental health in the workplace. We are encouraged ... The campaign also brings special focus to people living ... speak up and seek help from healthcare professionals and ...
(Date:5/29/2015)... The report “Muscle Spasm – Pipeline ... therapeutic development for Muscle Spasm. Spasms may affect ... leading to many different symptoms and presentations. The ... and MOAs to produce first-in-class and best-in-class products. ... Axillary Hyperhidrosis with 19 market data tables and ...
(Date:5/29/2015)... IL (PRWEB) May 29, 2015 The ... is giving patients a long-lasting impression on what modern ... of VisitandCare.com is on a mission to revolutionize the ... dentistry with a high-class Wellness & Spa. , ... the world’s most successful medical tourism agencies ...
(Date:5/29/2015)... Javlin continues to fulfill its worldwide ... a larger team, with the intention to better serve ... in the U.S. and Canada. , Javlin Inc., the ... growth in 2014 with its strongest earnings to date, ... platform, CloverETL. To accelerate further progress and ensure exceptional ...
(Date:5/29/2015)... Healthpointe is excited to announce that they are ... clinics in Orange County. The Supartz Therapy is a ... pain for patients with osteoarthritis, and will be administered ... Katz of Healthpointe. Supartz is an injection of made ... acid) a natural substance found in joint cartilage. Also ...
Breaking Medicine News(10 mins):Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Croatian Cosmetic Dentistry Providers New Approach to Revolutionize Cosmetic Dentistry 2Health News:Croatian Cosmetic Dentistry Providers New Approach to Revolutionize Cosmetic Dentistry 3Health News:Growth of Data Integration Platform CloverETL Continues in North America 2Health News:Healthpointe is Now Offering Supartz Joint Fluid Therapy at their Anaheim Clinic and La Mirada Clinic. 2
... resilient during real attack, experts say , , FRIDAY, Dec. 12 ... creation of a "mini heart attack" -- by cutting ... actually reduce the damage from a subsequent major heart attack. ... according to research from the University of Rochester Medical Center ...
... and protest are victorious in sham SEIU vote , ... statewide election while caregivers file over 125,000 protests , ... Final results in a statewide vote of healthcare workers conducted ... that healthcare workers overwhelmingly oppose their national union,s sham election. ...
... Health Care Policy and Legislative Background Assures Strong Leadership ... , , WASHINGTON, Dec. ... the nation,s largest cancer treatment and research networks representing ... selection of former Senator Tom Daschle to lead his ...
... who had relapsed saw disease stabilize or improve, ... -- A new combination of medicines designed to ... patients, according to interim results from an ongoing ... combining a new immunomodulatory drug called pomalidomide with ...
... enrolled,in Medicare Part D plans will spend more out-of-pocket ... access to them in 2009, according to new,research released ... Action Network (ACS CAN). , ... stand-alone prescription,drug plans (PDPs) have been increasingly shifting name-brand ...
... As cancer researchers move away from the general use ... working to discover effective ways to measure response and ... Cancer Symposium illustrate the cutting edge of biomarker discovery ... Density Predict Potential Benefit of Tamoxifen , Abstract ...
Cached Medicine News:Health News:Research Explains Benefit of 'Mini Heart Attack' 2Health News:Free Choice? Not For SEIU Members in California 2Health News:US Oncology Applauds Senator Daschle's Appointment as Director of President-Elect Obama's New White House Office of Health Reform 2Health News:Combo Therapy Helps Multiple Myeloma Patients 2Health News:Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009 2Health News:Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009 3Health News:Biomarkers: What can they tell us 2
... fiberoptic bronchoscopes offers a ... with a slim outside ... allows for improved suction ... cytology brushes. The scope ...
... fiberoptic imaging from the latest 60 ... its fiberscope range, focussing on providing ... image performance. Olympus has a impressive ... and therapy in the respiratory tract ...
... fiberoptic imaging from the latest 60 ... its fiberscope range, focussing on providing ... image performance. Olympus has a impressive ... and therapy in the respiratory tract ...
Indications For Usage: , Thoracic surgery. , Broncho-spirometry. , Thoracoscopies. , Differential or selective lung ventilation. , Lung Lavage. ...
Medicine Products: